Trametinib melanoma cancer drug. Trametinib is a cancer growth blocker drug used to treat melanoma skin cancer. It is a protein kinase inhibitor drug that inhibits MEK1 and MEK 2 proteins. Trametinib is used in patients that have a mutation in the BRAF gene. Patients who have had stage three melanoma skin cancer removed by surgery can also be given trametinib to reduce the risk of the cancer returning.
| px | px | dpi | = | cm | x | cm | = | MB |
Details
Creative#:
TOP26326896
Source:
達志影像
Authorization Type:
RM
Release Information:
須由TPG 完整授權
Model Release:
N/A
Property Release:
N/A
Right to Privacy:
No
Same folder images:
cancerdermatologicaldermatologydrugdrugshealthcaremedicalmedicationmedicinemekinistmelanomano-onenobodypharmaceuticalpharmaceuticspharmacologicalpharmacologyprescribedprescriptionskincancerstilllifestill-lifetrametinibwhitebackgroundgrowthblockermek1mek2inhibitordrugbrafgenebrafmutationbrafv600emekinhibitorproteinkinaseinhibitor
backgroundblockerbrafbrafbrafcancercancerdermatologicaldermatologydrugdrugdrugsgenegrowthhealthcareinhibitorinhibitorinhibitorkinaselifemedicalmedicationmedicinemekmek1mek2mekinistmelanomamutationno-onenobodypharmaceuticalpharmaceuticspharmacologicalpharmacologyprescribedprescriptionproteinskinstillstill-lifetrametinibv600ewhite
Loading